Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for ...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer.
The move positions Anthropic in a $100B+ drug discovery market that’s ripe for disruption, blending frontier models with ...
According to an August 25 press statement of the California Farm Bureau, protecting farmers’ right to grow genetically improved crops is crucial to efforts to develop renewable, economical biofuels ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...
InvestorsHub on MSN
XTL Biopharmaceuticals (XTLB) acquisition of Psyga Bio targets psychedelic biotech growth
XTL Biopharmaceuticals (NASDAQ:XTLB) announced an acquisition of Psyga Bio, a move that could reposition the company within ...
Bio-Techne is set to report its Q3 earnings with expectations of flat revenue and a slight EPS decline, against a backdrop of broader biotech funding challenges. Industry experts note early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results